Page 7 - manuscript_ijb05580
P. 7

their  survival  and  proliferation  through  enabling  the  passage  of  required  nutrients  for  cells  to

               survive at the PMs core. Among various polymers from natural and synthetic sources, poly(lactic-


               co-glycolic acid) (PLGA), a synthetic polymer approved by FDA, has garnered enormous interest

               in  the  field  of  biomaterials  due  to  the  favorable  mechanical  properties,  low  toxicity,  and  low


               immunogenicity  28,29 . It has been demonstrated that the cells are attached more rapidly to the PLGA-

               based PMs  with  a significantly enhanced growth rate compared to  the commercially  available


               porcine gelatin microcarriers 27,30-32 . Moreover, it should be noted that these PMs can be applied for

               drug delivery towards joint  diseases.  In a case,  Kaamini  designed the rapamycin encapsulated

               PLGA-based PMs, which demonstrated high residence time and co-localization with various joint


                                                                                    33
               tissues when administered in the mice knee via intra-articular injections . Such biomaterial-based
               delivery of rapamycin offered great potential for testing in animal models and clinical translation


               as  a  patient  compliant  treatment.  The  controllable  spatial  distribution  of  microsphere-based

               scaffolds could mimic the native tissues and thus form bone-like and cartilage-like macro-sized


               architectures 34-36 . Gelatin methacryloyl (GelMA) hydrogel has emerged as an ideal biomaterial for

               3D  bioprinting  owing  to  its  photo-crosslinkability,  excellent  biocompatibility,  and  tunable

               mechanical properties. Studies have demonstrated that the density of the molecular network (DMN)


               of GelMA can be precisely modulated by optimizing the degree of substitution  and solid content,

                                                                                    37
               enabling its compressive modulus to span a wide range of 3-123 kPa . This versatility allows

               GelMA to match the mechanical characteristics of various soft tissues such as liver, brain, and

               kidney.  Furthermore,  by  incorporating  reinforcing  materials,  GelMA-based  composites  can


               approach the mechanical requirements of stiffer tissues, including cartilage and bone. The innate

               RGD sequences in GelMA support cell adhesion and migration. Low-DMN formulations facilitate


               cell spreading and proliferation, supporting high cell viability (>95%), while high-DMN versions

               offer enhanced shape fidelity and mechanical stability, making them suitable for printing complex



                                                              6
   2   3   4   5   6   7   8   9   10   11   12